期刊文献+

溃疡性结肠炎肠黏膜组织PAR-2及COX-2表达及其相关性研究 被引量:4

Relative research between PAR-2 and COX-2 expressed in intestinal mucosa of patients with ulcerative colitis
下载PDF
导出
摘要 目的:研究溃疡性结肠炎(UC)患者肠黏膜蛋白酶激活受体2(PAR-2)及环氧合酶2(COX-2)表达情况及在UC发病机制中的作用。方法:UC患者36例,对照组33例,均行内镜检查并活检肠黏膜组织,应用组织病理学及免疫组织化学分析组织中PAR-2及COX-2表达情况。结果:UC患者肠黏膜PAR-2和COX-2表达均高于对照组(P<0.05)。重度UC组PAR-2及COX-2表达高于中度、轻度及对照组(P<0.05);病理Ⅰ~Ⅳ级病变肠黏膜中PAR-2表达均高于对照组(P<0.05),Ⅲ~Ⅳ级高于Ⅰ~Ⅱ级(P<0.05)。病理Ⅲ~Ⅳ级COX-2表达明显高于Ⅰ~Ⅱ级及对照组(P<0.05,P<0.01)。UC患者正规治疗,进入缓解期后两者表达明显下降(P<0.01)。在肠黏膜组织中PAR-2表达与COX-2表达呈正相关(r=0.501,P<0.01);均与UC病理分级呈正相关(P<0.05)。结论:UC的发生发展与PAR-2及COX-2过度表达密切相关,两者共同促进炎症的发生发展。 Objective: To investigate the expression of PAR-2 and COX-2 in intestinal mu- cosa of patients with ulcerative colitis, and the possible roles of PAR-2 and COX-2 in the patho- genesis of UC. Methods: Experimental colonic tissues were obtained from 36 patients with UC un- dergoing colonoscopy. Normal colon tissues were obtained from 33 healthy controls (UC patients with lesion mucosa, control group with normal mucosa). Histopathological examination and Im- munohistochemistry were used to determine the expression of PAR-2 and COX-2. Result: Se- vere UC group PAR-2 and COX-2 expression was higher than moderate, mild and control group. Expression of PAR-2 in the mucosa of patients with inflammation grade I -IV was significantly higher than that of the healthy control(P〈0.05). Grade III ~ IV exhibited significant higher expression than that of grade I - II (P〈0.05). The patients with inflammation grade tll- IV exhibited significant higher expression of COX-2 than that of grade I -II and the healthy control (P〈0.05 and P〈O.01), however the patients with inflammation grade t - II had no significant different expression of COX-2 (P〉0.05).The expression of PAR-2 and COX-2 in the colonic lesions mucosa of patients with UC was significant higher than that of the no lesions mucosa (P〈0.01).The expression of PAR-2 and COX-2 was significant lower after regular systemic treatment (P〈0.01). The expression of PAR-2 was positively correlated with the expression of COX-2(r=0.501, P〈0.01 ),and also positively corre- Lated with the pathological grade of UC (P〈O.05). Conclusion: The occurrence of UC correlated with the increased expression of PAR-2 and COX-2. PAR-2 and COX-2 had a close relationship and could jointly promote the development of inflammation.
出处 《中国现代普通外科进展》 CAS 2013年第2期107-111,共5页 Chinese Journal of Current Advances in General Surgery
关键词 溃疡 性结肠炎 蛋白酶激活受体-2 环氧合酶-2 Ulcerative colitis· Proteinase activated receptor-2·Cyclooxygenase -2
  • 相关文献

参考文献2

二级参考文献16

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.
  • 4欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84.
  • 5Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413.
  • 6Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753.
  • 7Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75.
  • 8Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643.
  • 9Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut, 2006, 55 Suppl 1:i1- i15.
  • 10Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut, 2004, 53 Suppl 5: Ⅴ1-Ⅴ16.

共引文献1045

同被引文献112

  • 1郑家驹.氨基水杨酸盐治疗炎症性肠病的药理学研究[J].中国药房,2005,16(13):1025-1028. 被引量:15
  • 2吴焕淦,施征,朱毅,马晓芃,姚怡,崔云华,赵天平,刘慧荣.隔药灸治疗溃疡性结肠炎的临床研究[J].上海针灸杂志,2007,26(4):3-4. 被引量:31
  • 3Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer in- cidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136: E359- E386.
  • 4Prakash S, Swaminathan U. ]3-catenin in health: A re- view. J Oral Maxillofac Pathol, 2015, 19:230-238.
  • 5Ueno K, Hirata H, Hinoda Y, et al. Frizzled homolog proteins, microRNAs and Wnt signaling in cancer. Int J Cancer, 2013, 132:1731-1740.
  • 6Chaw SY, Majeed AA, Dalley AJ, et al. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, [3-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation. Oral Oncol, 2012, 48: 997-1006.
  • 7Sawa M, Masuda M, Yamada T. Targeting the Wnt signaling pathway in colorectal cancer. Expert Opin Ther Targets, Published online: 06 Oct 2015. DOI: 10.1517/14728222.2016.1098619.
  • 8Qi L, Song W, Liu Z, et al. Wnt3a promotes the vas- culogenic mimicry formation of colon cancer via Wnt/ -catenin signaling. Int J Mol Sci, 2015, 16:18564-18579.
  • 9Qi L, Sun B, Liu Z, et al. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes co- lon cancer progression. J Exp Clin Cancer Res, 2014, 33: 107.
  • 10Guillen-Ahlers H, Suckow MA, Castellino F J, et al. Fas/ CD95 deficiency in APdi'/ mice intestinal tumor bur- den. PLoS One, 2010, 5:e9070.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部